Tailored kidney cancer trial vaccine shows recurrence-free survival
HQ Team February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%
HQ Team February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%
HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recall—the most severe category—for Medtronic’s Becker
Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.
The world’s first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the
Bharti Jayshankar February 4, 2025: Climate change has emerged as a significant factor influencing weather patterns across the globe, particularly in arid regions
Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global
Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish